Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Sawai Pharmaceutical Co., Ltd. manufactures, sells, imports, and exports pharmaceutical products. It offers drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, ophthalmic/nasal solutions, syrups, etc. in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, chemotherapeutics, vitamins, anti-cancer, etc. The company serves hospitals, general practitioners, and dispensing pharmacies. It has operations in Japan and the United States. The company was founded in 1929 and is headquartered in Osaka, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Equity (BVPS) 26.45
32.78
40.58
44.24
growth rate 7.4% 11.3% 9.0%
Earnings BIT 19,091.00
20,689.00
23,186.00
20,539.00
22,293.00
25,990.00
growth rate 8.4% 12.1% -11.4% 8.5% 16.6%
Avg.PE 19.42
14.47
14.76
10.79
10.79
10.79
growth rate -25.5% 2.0% -26.9% 0.0% 0.0%
ROA 6.49
7.24
7.51
9.57
8.80
8.91
9.21
7.44
4.83
5.30
5.09
growth rate 11.6% 3.7% 27.4% -8.1% 1.3% 3.4% -19.2% -35.1% 9.7% -4.0%
ROE 11.78
15.08
16.50
20.03
14.98
13.15
14.41
12.09
8.79
10.18
9.42
growth rate 28.0% 9.4% 21.4% -25.2% -12.2% 9.6% -16.1% -27.3% 15.8% -7.5%
ROIC 9.05
9.59
9.53
12.31
11.75
12.12
12.43
10.03
7.13
7.15
6.91
growth rate 6.0% -0.6% 29.2% -4.6% 3.2% 2.6% -19.3% -28.9% 0.3% -3.4%
Cur. Ratio 1.89
3.00
2.99
2.64
2.46
2.47
2.57
2.50
2.24
2.63
2.39
growth rate 58.7% -0.3% -11.7% -6.8% 0.4% 4.1% -2.7% -10.4% 17.4% -9.1%
Quick Ratio 1.10
2.10
1.94
1.56
1.38
1.31
1.30
1.23
1.33
1.72
1.43
growth rate 90.9% -7.6% -19.6% -11.5% -5.1% -0.8% -5.4% 8.1% 29.3% -16.9%
Leverage 1.83
2.30
2.11
2.08
1.47
1.48
1.64
1.61
1.98
1.87
1.83
growth rate 25.7% -8.3% -1.4% -29.3% 0.7% 10.8% -1.8% 23.0% -5.6% -2.1%
Balance Sheet Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Acct.Receivable 26,581.00
28,757.00
34,106.00
36,278.00
41,330.00
56,206.00
63,676.00
growth rate 8.2% 18.6% 6.4% 13.9% 36.0% 13.3%
Acct.Payable 11,941.00
16,157.00
17,054.00
22,176.00
22,481.00
39,909.00
43,434.00
growth rate 35.3% 5.6% 30.0% 1.4% 77.5% 8.8%
Cur.Assets 79,435.00
96,054.00
104,274.00
128,479.00
137,346.00
162,149.00
184,907.00
growth rate 20.9% 8.6% 23.2% 6.9% 18.1% 14.0%
Total Assets 127,842.00
149,348.00
166,179.00
206,492.00
221,538.00
358,453.00
372,889.00
growth rate 16.8% 11.3% 24.3% 7.3% 61.8% 4.0%
Cash 20,583.00
25,536.00
22,603.00
33,096.00
30,771.00
39,992.00
57,067.00
growth rate 24.1% -11.5% 46.4% -7.0% 30.0% 42.7%
Inventory 29,528.00
39,182.00
44,663.00
55,668.00
61,776.00
65,217.00
63,449.00
growth rate 32.7% 14.0% 24.6% 11.0% 5.6% -2.7%
Cur.Liabilities 30,105.00
39,097.00
42,208.00
50,079.00
54,875.00
72,275.00
70,350.00
growth rate 29.9% 8.0% 18.7% 9.6% 31.7% -2.7%
Liabilities 66,365.00
48,048.00
53,782.00
80,773.00
83,940.00
156,012.00
149,685.00
growth rate -27.6% 11.9% 50.2% 3.9% 85.9% -4.1%
LT Debt 33,865.00
6,373.00
8,630.00
26,864.00
25,263.00
79,787.00
75,005.00
growth rate -81.2% 35.4% 211.3% -6.0% 215.8% -6.0%
Equity 101,300.00
112,397.00
125,719.00
137,598.00
181,350.00
199,250.00
growth rate 11.0% 11.9% 9.5% 31.8% 9.9%
Common Shares 31.00
35.00
38.00
38.00
37.00
37.00
37.00
37.00
39.00
44.00
44.00
growth rate 12.9% 8.6% 0.0% -2.6% 0.0% 0.0% 0.0% 5.4% 12.8% 0.0%
Cash Flow Statement Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Capital Expenditures 4,003.00
7,021.00
12,296.00
17,453.00
15,461.00
10,319.00
7,500.00
growth rate 75.4% 75.1% 41.9% -11.4% -33.3% -27.3%
Cash Dividends 3,001.00
3,674.00
4,050.00
4,792.00
4,793.00
5,691.00
growth rate 22.4% 10.2% 18.3% 0.0% 18.7%
Cash From OA 12,255.00
13,422.00
12,112.00
19,975.00
20,628.00
28,472.00
42,923.00
growth rate 9.5% -9.8% 64.9% 3.3% 38.0% 50.8%
FCF per Share 1.29
0.69
3.76
5.12
growth rate -18.8% 133.4% 36.2%
Sale Purchase of Stock 234.00
223.00
462.00
growth rate -4.7% 107.2%
FCF 2,537.00
3,134.00
3,216.00
-264.00
6,070.00
-1,138.00
2,200.00
4,434.00
11,666.00
32,215.00
12,083.00
growth rate 23.5% 2.6% -100.0% 100.0% -100.0% 100.0% 101.6% 163.1% 176.1% -62.5%
Income Statement Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Sales 80,502.00
89,823.00
105,454.00
123,492.00
132,428.00
168,068.00
184,341.00
growth rate 11.6% 17.4% 17.1% 7.2% 26.9% 9.7%
Op.Income 12,022.00
19,091.00
20,689.00
23,186.00
20,539.00
22,293.00
25,990.00
growth rate 58.8% 8.4% 12.1% -11.4% 8.5% 16.6%
IBT 18,989.00
20,297.00
23,091.00
19,870.00
20,251.00
25,666.00
growth rate 6.9% 13.8% -14.0% 1.9% 26.7%
Net Income 12,022.00
12,192.00
14,053.00
17,155.00
15,914.00
14,017.00
19,376.00
growth rate 1.4% 15.3% 22.1% -7.2% -11.9% 38.2%
EPS 158.43
203.66
235.06
318.17
330.41
381.85
465.25
487.08
360.26
442.32
440.00
growth rate 28.6% 15.4% 35.4% 3.9% 15.6% 21.8% 4.7% -26.0% 22.8% -0.5%
Gross Profit 37,992.00
41,471.00
45,407.00
51,634.00
52,120.00
69,440.00
74,899.00
growth rate 9.2% 9.5% 13.7% 0.9% 33.2% 7.9%
R&D 5,170.00
6,109.00
8,019.00
10,207.00
14,533.00
16,671.00
growth rate 18.2% 31.3% 27.3% 42.4% 14.7%

Quarterly Statements

Item Name Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Earnings BIT 8,138.00
4,087.00
8,885.00
6,369.00
8,690.00
growth rate -49.8% 117.4% -28.3% 36.4%
Balance Sheet Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Acct.Receivable 77,319.00
63,676.00
63,117.00
57,415.00
67,979.00
growth rate -17.7% -0.9% -9.0% 18.4%
Acct.Payable 42,086.00
43,434.00
43,836.00
42,718.00
44,071.00
growth rate 3.2% 0.9% -2.6% 3.2%
Cur.Assets 181,823.00
184,907.00
187,822.00
186,493.00
192,338.00
growth rate 1.7% 1.6% -0.7% 3.1%
Total Assets 373,287.00
372,889.00
374,893.00
381,841.00
388,230.00
growth rate -0.1% 0.5% 1.9% 1.7%
Cash 41,548.00
57,067.00
55,513.00
54,141.00
48,972.00
growth rate 37.4% -2.7% -2.5% -9.6%
Inventory 62,391.00
63,449.00
67,324.00
73,346.00
74,415.00
growth rate 1.7% 6.1% 8.9% 1.5%
Cur.Liabilities 72,732.00
70,350.00
70,036.00
70,799.00
82,554.00
growth rate -3.3% -0.5% 1.1% 16.6%
Liabilities 153,696.00
149,685.00
152,132.00
154,200.00
154,924.00
growth rate -2.6% 1.6% 1.4% 0.5%
LT Debt 76,238.00
75,005.00
73,804.00
72,655.00
61,606.00
growth rate -1.6% -1.6% -1.6% -15.2%
Equity 196,598.00
199,250.00
199,648.00
204,333.00
209,352.00
growth rate 1.4% 0.2% 2.4% 2.5%
Common Shares 41,184.00
41,184.00
41,184.00
41,199.00
41,199.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Capital Expenditures 1,188.00
861.00
1,847.00
1,136.00
850.00
growth rate -27.5% 114.5% -38.5% -25.2%
Cash Dividends 2,846.00
3,064.00
3,064.00
2,846.00
2,846.00
growth rate 7.7% 0.0% -7.1% 0.0%
Cash From OA 19,373.00
24,487.00
6,073.00
9,087.00
1,980.00
growth rate 26.4% -75.2% 49.6% -78.2%
FCF 18,185.00
23,626.00
4,226.00
7,951.00
1,130.00
growth rate 29.9% -82.1% 88.1% -85.8%
Income Statement Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Sales 49,206.00
46,344.00
47,134.00
43,347.00
49,785.00
growth rate -5.8% 1.7% -8.0% 14.9%
Op.Income 8,138.00
4,087.00
8,885.00
6,369.00
8,690.00
growth rate -49.8% 117.4% -28.3% 36.4%
IBT 8,136.00
3,839.00
8,900.00
6,253.00
8,633.00
growth rate -52.8% 131.8% -29.7% 38.1%
Net Income 6,287.00
2,572.00
6,436.00
4,536.00
6,347.00
growth rate -59.1% 150.2% -29.5% 39.9%
Gross Profit 19,122.00
19,345.00
19,902.00
17,319.00
19,907.00
growth rate 1.2% 2.9% -13.0% 14.9%
R&D 3,204.00
6,512.00
3,514.00
2,838.00
3,118.00
growth rate 103.3% -46.0% -19.2% 9.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (73.81)

YOY Growth Grade:

C (65.86)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 10.79 10.79
EPS / Growth 4.09

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 15.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 15.3% 15.3% 15.3%
Future PE 0.01 7.20 13.83
Future EPS 17.05 17.05 17.05
Value Price
MOS %
0.04
30.32
58.26
MOS Price 0.02 15.16 29.13
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.